BlockBeats News, February 6th, GoPlus Security recently launched GoPlus AgentGuard, a native security Skill for AI Agents designed to address the emerging execution-level security risks of AI Agents.
As AI Agents begin to possess real execution capabilities (such as command execution, file read/write, service invocation, and on-chain transactions and signing), the risk has escalated from "answering incorrectly" to potential execution risks that could directly cause system damage, data leakage, or financial loss. Leveraging its long-term technical expertise in Web3 on-chain security and transaction risk control, GoPlus has preemptively embedded security capabilities before AI execution takes place.
Through a "runtime interception + on-demand deep scanning" mechanism, GoPlus AgentGuard intercepts, confirms, or allows high-risk behaviors, assessing action risks before AI Agent execution. This is a dedicated execution-level security mechanism that prevents AI Agents from "misexecution, unauthorized execution, dangerous execution," enabling users to securely and confidently use OpenClaw. AgentGuard is now open source and available for use by AI Builders and developers.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.



Key Takeaways GoPlus Security revealed a vulnerability in a contract resembling those of ListaDAO. ListaDAO confirmed that their…










Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.


Key Takeaways GoPlus Security revealed a vulnerability in a contract resembling those of ListaDAO. ListaDAO confirmed that their…